Real-time enrollment status for this advanced solid tumors clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 2:48 AM UTC
| NCT Number | NCT06004245 |
| Recruiting Status | Recruiting |
| Condition | Advanced Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 280 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Vividion Therapeutics, Inc. |
| Last Updated on CT.gov | August 17, 2026 (1 week ago) |
As of August 28, 2026: Clinical trial NCT06004245 is currently recruiting participants. This phase1 study for advanced solid tumors is actively seeking new participants at 16 locations across the United States. The study is sponsored by Vividion Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06004245 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06004245 was last updated 1 week ago (August 17, 2026). HelloStudys verifies this status automatically.